首页> 外文学位 >Epigenetic mechanisms regulating activation of the TAL1 oncogene in normal and in malignant hematopoiesis.
【24h】

Epigenetic mechanisms regulating activation of the TAL1 oncogene in normal and in malignant hematopoiesis.

机译:表观遗传机制调节正常和恶性造血过程中TAL1癌基因的激活。

获取原文
获取原文并翻译 | 示例

摘要

TAL1/SCL is a critical transcription factor required for development of all hematopoietic lineages; yet, aberrant TAL1 transcription which is frequently observed in T-cell acute lymphoblastic leukemia (T-ALL), leads to leukemia manifestation. Therefore to dissect the underlying epigenetic mechanisms regulating TAL1 gene activity in normal and in malignant hematopoiesis this study was undertaken.;Here, we report that TAL1 expression is regulated by differential intra- and inter-chromosomal chromatin loops in normal and leukemia cells, respectively. These loops determine which cell-type specific enhancers interact with the TAL1 promoter. The TAL1 +51 enhancer which is specifically active in erythroid precursors and inactive in leukemic T-cells, interacts with the upstream TAL1 promoter 1 via an activating chromatin loop. hSET1 mediated H3K4 methylation facilitates this erythroid-specific long-range chromatin interaction, and regulates RNA poIII recruitment at the TAL1 locus. hSET1 is further required for hematopoietic stem cells (CD34+) capacity to generate burst forming and colony forming units. Furthermore, we find that insulator protein CTCF differentially reorganizes the TAL1 locus chromatin structure keeping the +51 enhancer in a close proximity to the TAL1 promoter in erythroid cells while blocking the same enhancer/promoter interaction in T-ALL.;In addition, we identify the role of LIM domain binding protein 1 (Ldb1) in TAL1 gene activation by regulating TAL1 +51 enhancer and promoter 1 interaction in erythroid cells. Altogether, this study provides a mechanistic insight into the epigenetic mechanisms that function to regulate long-range chromatin interactions at the TAL1 locus, to modulate TAL1 gene activity in normal and malignant hematopoiesis.
机译:TAL1 / SCL是所有造血谱系发育所需的关键转录因子;然而,经常在T细胞急性淋巴细胞白血病(T-ALL)中观察到的异常TAL1转录导致白血病的表现。因此,本研究旨在剖析调节正常和恶性造血过程中TAL1基因活性的潜在表观遗传机制。在此,我们报道TAL1的表达分别受正常和白血病细胞中染色体间染色质环和染色体间染色质环的调节。这些环决定了哪些细胞类型特异性增强子与TAL1启动子相互作用。 TAL1 +51增强子在类红细胞前体中有活性,在白血病T细胞中无活性,通过激活的染色质环与上游TAL1启动子1相互作用。 hSET1介导的H3K4甲基化促进这种类红细胞特异性长距离染色质相互作用,并调节TAL1基因座处的RNA poIII募集。造血干细胞(CD34 +)产生爆发形成和集落形成单位的能力还需要hSET1。此外,我们发现绝缘蛋白CTCF差异重组TAL1基因座染色质结构,使+51增强子与红细胞中的TAL1启动子紧密相邻,同时阻断了T-ALL中相同的增强子/启动子相互作用。 LIM域结合蛋白1(Ldb1)在红细胞中通过调节TAL1 +51增强子和启动子1相互作用在TAL1基因激活中的作用。总而言之,这项研究为表观遗传机制提供了机制上的见解,这些机制在TAL1基因座处调节长距离染色质相互作用,调节正常和恶性造血过程中的TAL1基因活性。

著录项

  • 作者

    Patel, Bhavita.;

  • 作者单位

    University of Florida.;

  • 授予单位 University of Florida.;
  • 学科 Biology Molecular.;Health Sciences Oncology.;Chemistry Biochemistry.
  • 学位 Ph.D.
  • 年度 2013
  • 页码 127 p.
  • 总页数 127
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号